0001062993-21-012053.txt : 20211202
0001062993-21-012053.hdr.sgml : 20211202
20211202184930
ACCESSION NUMBER: 0001062993-21-012053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211130
FILED AS OF DATE: 20211202
DATE AS OF CHANGE: 20211202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HURWITZ EDWARD
CENTRAL INDEX KEY: 0001211840
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36370
FILM NUMBER: 211468212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001273636
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 593553710
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14193 NW 119TH TERRACE
STREET 2: SUITE #10
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: 386-462-2204
MAIL ADDRESS:
STREET 1: 14193 NW 119TH TERRACE
STREET 2: SUITE #10
CITY: ALACHUA
STATE: FL
ZIP: 32615
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2021-11-30
0001273636
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
0001211840
HURWITZ EDWARD
C/O APPLIED GENETIC TECHNOLOGIES CORP.
14193 NW 119TH TERRACE, SUITE #10
ALACHUA
FL
32615
1
0
0
0
Stock Option (right to buy)
2.17
2021-11-30
4
A
0
14000
0
A
2031-11-30
Common Stock
14000
14000
D
The option becomes exercisable in equal monthly installments over one year from the date of grant.
/s/ Stacie Aarestad, Attorney-in-fact
2021-12-02